Dr Paul Edosa Aifesehi, MD, MPH in Fort Worth, TX - Student in an Organized Health Care Education/Training Program

Dr Paul Edosa Aifesehi, MD, MPH is a Student In An Organized Health Care Education/training Program physician based in Fort Worth, Texas. Dr Paul Edosa Aifesehi is licensed to practice in Texas (license number ) and his current practice location is 1301 Pennsylvania Ave, Fort Worth, Texas. He can be reached at his office (for appointments etc.) via phone at (817) 250-3117.

NPI number for Dr Paul Edosa Aifesehi is 1285009050 and his current mailing address is Po Box 858, Hershey, Pennsylvania. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1285009050.

Contact Information

	Dr Paul Edosa Aifesehi, MD, MPH
	1301 Pennsylvania Ave, Fort Worth, TX 76104-2122
	(817) 250-3117
	Not Available

Physician's Profile

Full Name	Dr Paul Edosa Aifesehi
Gender	Male
Speciality	Student In An Organized Health Care Education/training Program
Location	1301 Pennsylvania Ave, Fort Worth, Texas
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1285009050
Provider Enumeration Date: 12/05/2015
Last Update Date: 03/22/2021

Medical Identifiers

Medical identifiers for Dr Paul Edosa Aifesehi such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1285009050	NPI	-	NPPES
1033559050001	Medicaid	PA

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208G00000X	Thoracic Surgery (cardiothoracic Vascular Surgery)	LT000792 (Pennsylvania)	Secondary
390200000X	Student In An Organized Health Care Education/training Program	P00296 (New York)	Secondary
390200000X	Student In An Organized Health Care Education/training Program	(Texas)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Paul Edosa Aifesehi is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Paul Edosa Aifesehi, MD, MPH Po Box 858, Hershey, PA 17033-0858 Ph: (800) 243-1455	Dr Paul Edosa Aifesehi, MD, MPH 1301 Pennsylvania Ave, Fort Worth, TX 76104-2122 Ph: (817) 250-3117

News Archive

Nutritional study shows wide range of metabolic responses after eating in healthy adults

Researchers led by King's College London announced today the first published results from PREDICT, the largest ongoing nutritional study of its kind.

GFG's 'A Bite for the Fight' campaign raises over $1 million for The Leukemia & Lymphoma Society

Global Franchise Group, LLC, the strategic brand management company and franchisor behind Great American Cookies, Pretzelmaker, Marble Slab Creamery, MaggieMoo's Ice Cream & Treatery, and Hot Dog on a Stick has raised more than $1 million for The Leukemia & Lymphoma Society through its "A Bite for the Fight" campaign.

Study provides novel insight into the impact of genes on Huntington's disease

A study led by researchers at Boston University School of Medicine provides novel insight into the impact that genes may have on Huntington's disease (HD). The study, published online in PLOS Genetics, identified specific small segments of RNA (called micro RNA or miRNA) encoded in DNA in the human genome that are highly expressed in HD.

CEL-SCI receives no objection letter to initiate Phase III clinical trial of Multikine in Canada

CEL-SCI Corporation announced today that the Biologics and Genetic Therapeutics Directorate of Health Canada has issued a final "no objection" letter for CEL-SCI to be able to begin enrollment of patients for a Phase III clinical trial of Multikine in Canada.

Leicester research could help identify people with asthma of different severities

A team of researchers from the NIHR Leicester Biomedical Research Centre – a partnership between Leicester's Hospitals, the University of Leicester and Loughborough University - has identified biological variations in lung tissue samples that for the first time can help identify people with mild asthma from those with moderate or severe asthma.

Dr Paul Edosa Aifesehi, MD, MPH - Student in an Organized Health Care Education/Training Program in Fort Worth, TX